Paul D. Rubin, Senior VP Clinical Development & CMO at XOMA Corp (XOMA), sold 26,748 shares at $4.36 ($116K) on 2014-08-18, disclosed to the SEC on 2014-08-19.
Scheduled sale ($116k) by Senior VP Clinical Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.31 | 10,299 | $44K | 38.2% |
| 2 | $4.36 | 16,449 | $72K | 61.8% |
| Total | $4.34 avg | 26,748 | $116K | 100% |
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |